îæ€çŽ¢
îæ€çŽ¢
î
NRX Pharmaceuticals Inc
NRXPîãŠã©ãããªã¹ãã«è¿œå
3.870USD
+0.010+0.26%
çµå€Â 07/02, 13:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
140.21Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
åçäºæž¬
é貚: USD æŽæ°æå»: 2026-07-02NRX Pharmaceuticals Incã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯8.40ã§ããã€ãªãã¯ãããžãŒ & å»çç 究æ¥çã§ã¯387瀟äž128äœã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯37.00ã§ãæé«ã¯47.00ãæäœã¯25.00ã§ãã
ã¢ããªã¹ãè©äŸ¡
5
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
40.400
ç®æšæ ªäŸ¡
+910.00%
äžæäœå°
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
åæ¥ä»ç€Ÿæ¯èŒ
562
åèš
5
äžå€®å€
6
å¹³å
äŒç€Ÿå
è©äŸ¡
ã¢ããªã¹ã
NRX Pharmaceuticals Inc
NRXP
5
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
CRISPR Therapeutics AG
CRSP
26
1
2
3
...
113
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åäºæž¬
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
ãããã質å
NRX Pharmaceuticals Inc ã®æ¬¡ã®ååæã®åçã¯ãããã§ãã?
îNRX Pharmaceuticals Inc ã®äºæ³åç㯠16.56M ã§ãã
NRX Pharmaceuticals Inc ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãNRX Pharmaceuticals Inc ã®ç®æšæ ªäŸ¡ã USD 37.00 ãšäºæ³ããæé«äºæ³ã¯ USD 47.00ãæäœäºæ³ã¯ USD 25.00 ãšäºæ³ããŠããŸãã
NRX Pharmaceuticals IncNRXP ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD -0.04 ã§ããããNRX Pharmaceuticals IncNRXP ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD 0.01 ã§ããã次ã®ååæã® EPS 㯠USD 0.06 ãšäºæ³ãããŸãã
NRX Pharmaceuticals Inc ã«å¯Ÿããã¢ããªã¹ãã®è©äŸ¡ã¯äœã§ãã?
î5 ã¢ããªã¹ãã«ãã NRX Pharmaceuticals Inc æ ªã®è©äŸ¡ã«åºã¥ããšãã»ãšãã©ã®ã¢ããªã¹ã㯠買ã ã®ãã¬ã³ããæ¯æããŠããŸããä»ã®ã¢ããªã¹ãã®æèŠãèæ
®ããçµæãæçµçã« NRX Pharmaceuticals Inc ã®æ ªäŸ¡ã¯ è²·ã ãšè©äŸ¡ãããŸããããã¯ååŒã«é¢ããã¢ããã€ã¹ã§ã¯ãªãããšã«æ³šæããŠãã ããããã¯ãç¬èªã®åæãè¡ãå¿
èŠããããŸãã